Clofarabine, Cytarabine, and G-CSF in Treating Patients With Myelodysplastic Syndromes

NCT00503880 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Genzyme discontinued Funding

Conditions

Myelodysplastic Syndromes

Interventions

BIOLOGICAL: filgrastim
DRUG: clofarabine
DRUG: cytarabine
GENETIC: microarray analysis
PROCEDURE: biopsy

Sponsor

University of Nebraska

Collaborators

[object Object]